"Our 2016 Young Investigators encapsulate the future of cancer care, and we take great pride in our investment in these remarkable researchers," said Jonathan W. Simons, MD, president and CEO of PCF. "By leveraging the most current advances in biotechnology, they are poised to break new ground in immunotherapy and precision medicine, and establish novel modalities for optimizing existing therapies for better patient outcomes in the near term."
June 27, 2016
Prostate Cancer Foundation rewards U-M Urology's Dr. Simpa Salami with Young Investigator Award
The awards, which support the development of increasingly precise treatments and faster cures for prostate cancer, were given to Dr. Salami and 23 other doctors.
